• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by PACS Group Inc.

    11/19/25 4:07:14 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    S-8 1 pacsgroupincs-82025.htm S-8 Document


    As filed with the Securities and Exchange Commission on November 19, 2025
    Registration No. 333-
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933
    PACS Group, Inc.
    (Exact name of Registrant as specified in its charter)
    Delaware92-3144268
    (State or other jurisdiction of
    incorporation or organization)
    (I.R.S. Employer
    Identification Number)
    262 N. University Ave.
    Farmington, Utah
    84025
    (Address of Principal Executive Offices)(Zip Code)
    2024 Incentive Award Plan
    2024 Employee Stock Purchase Plan
    (Full Title of the Plan)
    Jason Murray
    Chief Executive Officer
    PACS Group, Inc.
    262 N. University Ave.
    Farmington, Utah 84025
    (801) 447-9829
    (Name, address, including zip code, and telephone number, including area code, of agent for service)
    Copies to:
    John Mitchell
    Chief Legal Officer and General Counsel
    262 N. University Ave.
    Farmington, Utah 84025
    (801) 447-9829
    Jenna B. Cooper
    Joel H. Trotter
    J. Ross McAloon
    Latham & Watkins LLP
    650 Town Center Drive, Floor 20
    Costa Mesa, California 92626
    (714) 540-1235




    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated fileroAccelerated filero
    Non-accelerated filerxSmaller reporting companyo
    Emerging growth companyo
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o 

    Explanatory Note
    This Registration Statement on Form S-8 is being filed with the Securities and Exchange Commission for the purpose of registering an additional 4,655,325 shares of common stock, par value $0.001 per share (the “Common Stock”), of PACS Group, Inc. (the “Registrant”), issuable under the following employee benefit plans for which registration statement of the Registrant on Form S-8 (File No. 333-278615) is effective: (i) the PACS Group, Inc. 2024 Incentive Award Plan and (ii) the PACS Group, Inc. 2024 Employee Stock Purchase Plan.
    Pursuant to General Instruction E of Form S-8, the contents of the above-referenced prior registration statements are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.



    Item 8. Exhibits.
    Exhibit
    Number
    Exhibit DescriptionFormFile No.Filing DateExhibit
    Filed
    Herewith
    4.1
    Amended and Restated Certificate of Incorporation of PACS Group, Inc. 
    S-1/A333-27789304/01/243.2
    4.2
    Amended and Restated Bylaws of PACS Group, Inc.
    S-1/A333-27789304/01/243.4
    4.3
    Form of Certificate of Common Stock
    S-1/A333-27789304/08/244.1
    5.1
    Opinion of Latham & Watkins LLP
    X
    23.1
    Consent of Latham & Watkins LLP (included in Exhibit 5.1)
    X
    23.2
    Consent of Ernst & Young LLP, independent registered public accounting firm
    X
    24.1
    Power of Attorney (included on signature page)
    X
    99.1
    PACS Group, Inc. 2024 Incentive Award Plan
    S-8333-27861504/11/2499.1
    99.2
    Form of Stock Option Agreement under PACS Group, Inc. 2024 Incentive Award Plan
    S-8333-27861504/11/2499.2
    99.3
    Form of Restricted Stock Unit Agreement under PACS Group, Inc. 2024 Incentive Award Plan
    S-8333-27861504/11/2499.3
    99.4
    Form of Restricted Stock Unit Award Agreement (Executive IPO Awards) under PACS Group, Inc. 2024 Incentive Award Plan
    S-8333-27861504/11/2499.4
    99.5
    PACS Group, Inc. 2024 Employee Stock Purchase Plan
    S-8333-27861504/11/2499.5
    107.1
    Registration Fee Table
    X





    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Farmington, State of Utah, on this 19th day of November, 2025.
    PACS Group, Inc.
    By:/s/ Jason Murray
    Jason Murray
    Chief Executive Officer
    POWER OF ATTORNEY
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Jason Murray and John Mitchell, and each of them, with full power of substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file this registration statement, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.
    Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.
    SignatureTitleDate
    /s/ Jason Murray
    Director, Chairman and Chief Executive Officer
    (Principal Executive Officer)
    November 19, 2025
    Jason Murray
    /s/ Mark Hancock
    Director, Executive Vice Chairman, and Interim Chief Financial Officer
    (Principal Financial Officer)
    November 19, 2025
    Mark Hancock
    /s/ Michelle Lewis
    Chief Accounting Officer
    (Principal Accounting Officer)
    November 19, 2025
    Michelle Lewis
    /s/ Evelyn DilsaverDirectorNovember 19, 2025
    Evelyn Dilsaver
    /s/ Jacqueline MillardDirectorNovember 19, 2025
    Jacqueline Millard
    /s/ Taylor LeavittDirectorNovember 19, 2025
    Taylor Leavitt

    Get the next $PACS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Announces NYSE Listing Extension and Provides Select Preliminary Interim Operating Metrics

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), on September 10, 2025, announced that on September 9, 2025, the New York Stock Exchange ("NYSE") Listing Operations Committee agreed to provide the Company with an additional trading period through November 19, 2025, subject to its ongoing review of the Company. The additional trading period provides PACS additional time to complete the previously announced restatement of its financial statements for the three months ended March 31, 2024, and the three and six months ended June 30, 2024 and become current with its SEC filing obligations, which are required for the Company to regain compliance with the NYSE listing standards. "We have

    9/11/25 8:17:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    PACS Group downgraded by Analyst with a new price target

    Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

    12/17/24 8:16:05 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    JP Morgan resumed coverage on PACS Group with a new price target

    JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

    11/6/24 6:27:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    UBS initiated coverage on PACS Group with a new price target

    UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00

    10/9/24 7:56:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 16,777 shares, decreasing direct ownership by 5% to 326,591 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:32:30 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Compliance Officer Lee Joseph Robert covered exercise/tax liability with 28,763 shares, decreasing direct ownership by 4% to 648,122 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:31:48 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Officer Sanford Peter covered exercise/tax liability with 72,924 shares, decreasing direct ownership by 5% to 1,280,872 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:31:05 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    SEC Filings

    View All

    SEC Form S-8 filed by PACS Group Inc.

    S-8 - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:07:14 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:06:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by PACS Group Inc.

    10-Q - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:05:41 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:49 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:15 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 11:37:42 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Financials

    Live finance-specific insights

    View All

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Provides Preliminary Third Quarter Operational Metrics

    Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op

    11/6/24 6:00:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care